News
Elon Musk’s Neuralink is a last chance at a normal life for some
Kate Kegans doesn’t own a Tesla or any other products from Elon Musk’s many entities. Still, his Neuralink program could be her last chance at a normal life after experiencing vision impairments nearly nine years ago.
“I started having double vision, especially when I looked down,” Kegans said about her initial symptoms in 2011. “I went to my ophthalmologist. He goofed around with contact lenses for a year with no improvement, so my General Physician recommended a specialist.” An MRI revealed a cavernous malformation on her brain stem, which sent her to a Brain and Spine specialist in Phoenix, Arizona.
After having one resection of the malformation in 2011, the issues didn’t resurface for three years, until the doctor who performed the first surgery performed another one in 2015. However, the 2015 surgery didn’t go all the way to completion after “unfavorable conditions” aborted the effort once the surgery began.
Kate then underwent a third surgery to attempt the resection of the cavernous malformation in July 2018. While doctors called this surgery a success, Kegans has not lived a normal life since. After the surgery, she began experiencing symptoms that came to be recognized as signs of complete hemi-body dysesthesia, which included freezing and burning sensations on the right side of her body, and the inability to feel temperature changes on that side, making her prone to burns and scalds.
“Honestly, at this point, I wish I had not done the procedure, and dealt with the ‘ticking time bomb’ instead,” she said. As a result, Kegans has been forced to look at nearly every option due to relatively no improvement in her condition.
“I have tried extensive surgical procedures to ‘fix’ this,” she told Teslarati. Kegans then outlined the extensive list of treatments that have come to no resolve for her issues. Everything from Deep Brain Stimulation (the process of sending electrical impulses to specific targets in the brain), an Intrathecal Catheter with PRIALT (a pump placed in the body with a direct line that delivers medication into the spinal fluid), multiple cingulotomies (a surgery where tissue in the anterior cingulate region of the brain is altered, creating a lesion), Gamma Knife Radiation (surgery that destroys precisely selected areas of tissue by using radiation and not a blade), and a mesencephalotomy (an ablative procedure which lesions the pain pathways at the midbrain level to treat pain), all have had no effect on her condition.
In fact, one surgery disrupted her vision, an issue that was eventually fixed with another episode that took Kegans under the knife in November 2019. After it was fixed, the mesencephalotomy, which took place in July 2020, disrupted her vision once again. After having another surgery just eight weeks ago to improve her vision, she states that it still has not been fixed.
After trying a non-surgical route through various medications, including ketamine infusions, medicinal marijuana, gabapentin, and naltrexone, Kegans has one more option, as she says she is desperate. “I am willing to try anything to get back to normal.”
Enter: Neuralink
In August 2020, Elon Musk unveiled the “Link v0.9,” Neuralink’s latest and greatest implant device aimed to begin the surge toward curing various neurological diseases. A few sassy pigs with Neuralink chips implanted in their brains were among the first publicly unveiled test subjects. One, in particular, Gertrude, was a great example of how Neuralink could be used to battle various neurological diseases, including the loss of limb function.
Elon Musk’s Neuralink unveils sleek V0.9 device, uses sassy pigs for live brain machine demo
The Neuralink implant was able to predict all the limb movements based on the neural activity that was being read. With all of the improvements and developments in the Neuralink chip, many became believers in Musk’s most recent endeavor. One of them, a friend of Kegans, who sent her information about the pigs from the demonstration.
“My friend, who is a nurse, sent me an article on Neuralink. They said that human trials would eventually start,” Kegans said.
Neuralink has a handful of problems that it plans to solve on the neurological spectrum of injuries. Everything from memory loss, to blindness, to paralysis, to seizures will be a target for the chip. Another one is extreme pain, something that Kegans experiences on a daily basis, and it has affected her ability to live a normal life for years.
“I am 57 years old,” she said. “I used to be very active, and I need help returning to a normal life. I have zero quality of life now, and I am willing to try anything to get back to normal.”
FDA Designation, and what lies ahead for Neuralink’s possible patients
In July, the Food and Drug Administration (FDA) gave Neuralink a “breakthrough device” designation, allowing the company to continue working with its Link v0.9. Eventually, the device could be sewn deeper into the brain, allowing for a wider variety of functions beyond the upper cortex. Some of the issues that could be solved would deal with addiction, depression, and motor function.
As of now, human trials are the next step for Neuralink to make some real noise in the medical sector. On February 1st, Musk gave an update regarding Neuralink’s development with the FDA, where he indicated the company was in constant communication with the federal agency to ensure implant safety.
Neuralink is working super hard to ensure implant safety & is in close communication with the FDA. If things go well, we might be able to do initial human trials later this year.
— Elon Musk (@elonmusk) February 1, 2021
After stating that human trials could begin as soon as this year, several people, Kegans included, reached out to talk about the possibility of being included in the first Neuralink trials. While no details are known yet, there are plenty of people out there who have been affected by severe brain injuries that have negatively altered their lives. Neuralink could be the key to eventually making neurological disorders a thing of the past, especially as the company plans to create a chip that will be affordable for virtually everyone.
In the world of autonomous ride-hailing, there are only a handful of names. Among those few companies lies a strategy play by each to keep the opposition on their toes. Tesla, on the other hand, already tipped its hand at where it is headed next.
Tesla has signaled its next major push in the autonomous ride-hailing market by filing for an Autonomous Vehicle Network Company permit in Nevada (Docket 26-05015). Through Tesla Robotaxi, LLC, the company seeks approval to operate up to 5,000 robotaxis in Clark County, including high-traffic areas like Las Vegas and Henderson airports, within the first 12 months of launch.
This filing builds on Tesla’s earlier testing approvals from the Nevada DMV in September 2025 and preparations such as maintenance hubs in the Las Vegas area. Nevada represents a strategic expansion into a major tourist destination, where high visitor volumes could drive strong utilization and showcase the reliability of unsupervised autonomy to a broad audience.
We’d have to assume this means Tesla is targeting Las Vegas, and it’s a great move from a business perspective.
Vegas is such a melting pot of people from all around the country and the world. It will expose people from all corners of the globe to Tesla’s autonomy capabilities https://t.co/Qz3fQmhULF pic.twitter.com/Du5pj2RyWC
— TESLARATI (@Teslarati) June 6, 2026
Approval would mark a significant step toward commercial operations in a new state, following progress in Texas.
Tesla’s shareholder decks and earnings calls have clearly outlined these ambitions. In the Q4 2025 shareholder deck, the company listed planned Robotaxi coverage for the first half of 2026, explicitly naming Las Vegas alongside Phoenix, Miami, Orlando, and Tampa, with Dallas and Houston already advancing. Austin was noted as “ramping unsupervised,” while the Bay Area remained in safety-driver mode.
By Q1 2026, the deck updated statuses to reflect launches in Dallas and Houston, with “preparations underway” for the remaining cities, including Las Vegas. Paid Robotaxi miles nearly doubled sequentially in Q1, underscoring momentum even as broader timelines adjusted slightly for regulatory and operational readiness.
On earnings calls, CEO Elon Musk and executives have emphasized a phased rollout prioritizing safety. Unsupervised operations in Texas have shown strong results with no reported accidents or injuries in the program. Tesla continues groundwork in additional major U.S. metros through testing and permitting, positioning it to scale quickly once approvals clear.
This Nevada move aligns with Tesla’s vision of transforming from an EV maker into an AI and robotics leader. The forthcoming Cybercab, which started production at Giga Texas in April, is expected to eventually dominate the fleet, replacing many Model Y vehicles and driving down costs to enable affordable rides.
For investors and the industry, this signals Tesla’s intent to dominate key Sun Belt and tourist markets where weather, regulations, and demand favor rapid scaling. Success in Las Vegas could validate the model for denser urban and high-tourism environments, accelerating the shift toward a future where robotaxis generate meaningful revenue.
Las Vegas will also expand knowledge among the general public at Tesla’s capabilities, helping people experience driverless ride-hailing from several companies during their time on The Strip.
The Tesla Model 3’s cheapest trim level just got a major accolade, as Edmunds just revealed the Rear-Wheel-Drive trim of the all-electric sedan is the most efficient EV that is currently in production.
The 2026 Tesla Model 3 Rear-Wheel-Drive not only beat its EPA-estimated range by 30 miles, but it also bested its efficiency mark by 13.2 percent. The Model 3 tested by Edmunds traveled 393 miles, beating its EPA rating by 8.3 percent, while it returned 21.7 kWh per 100 miles, or 4.61 mi/kWh.
Beating those two metrics is especially pertinent when it comes to EV ownership and driving down the cost of ownership from ICE counterparts across the board. The real money savings come from driving down the cost of driving per mile, especially when it comes to high-mileage driving.
Edmunds stated in its report and review that the process it uses to test EV efficiency is aimed at giving “the most accurate representation of a car’s real-world range.” The assessment uses a strict route that features 60 percent city and 40 percent highway driving, and an average speed of 40 MPH across the trip.
It also drives each car within 5 MPH of all posted speed limits, and the climate control is set on Auto at 72 degrees to ensure even testing. In other words, Edmunds does not use methods to maximize efficiency, and instead tries to make it reasonable to achieve the same ratings yourself.
In comparison to other EVs, it beat the 2026 Mercedes-Benz CLA 350, which went 385 miles, as well as the 2026 Audi A6 Sportback E-tron Prestige AWD, which traveled 392 miles. Only the Mercedes-Benz CLA 250+ traveled farther, making it an impressive 434 miles on a charge.
However, the Tesla Model 3 RWD’s efficiency is “unmatched” because of its incredibly low energy usage per mile.
🚨 Tesla Model 3 RWD:
-At $36,990, it is $9,000 cheaper than the average transaction price for a new car ($46,023 via KBB)
-Was 13.2% more efficient than its EPA estimate
-Traveled 393 miles on a charge despite its 363-mile EPA range https://t.co/Grov2hXqpa pic.twitter.com/Zl8rnZZLIB
— TESLARATI (@Teslarati) June 8, 2026
The Model 3 Rear-Wheel-Drive might be the best bang-for-your-buck EV if you’re looking to buy new and want access to features like Full Self-Driving, while also being aware of efficiency. This trim of the Model 3 is also priced over $9,000 cheaper than what Kelley Blue Book says the average transactional price for a new car was in May 2026, which sits at $46,023.
If you’re looking for something with more speed, an All-Wheel-Drive drivetrain, or more premium features, the Premium trims of the Model 3 currently come with one year of Free Supercharging.
The Ontario Teachers’ Pension Plan (OTPP) stands to reap one of the most extraordinary returns in pension fund history thanks to a bold 2019 investment in SpaceX.
According to a recent report from The Globe and Mail, the Toronto-based fund invested roughly $300 million CAD (~$220 million USD at the time) in Elon Musk’s space company as its inaugural deal through the Teachers’ Innovation Platform.
At SpaceX’s anticipated $1.75 trillion IPO valuation, set for a mid-June debut on Nasdaq under ticker $SPCX, that stake could now be worth up to $11.6 billion USD. This would represent a roughly 50x return and easily become OTPP’s most successful single investment ever.
The fund manages $279 billion in assets for approximately 346,000 working and retired teachers in Ontario, potentially delivering an average boost of around $33,500 per member if fully realized.
SpaceX has filed its S-1 and plans to price shares at $135 each, aiming to raise a record $75 billion in what would be the largest IPO in history, surpassing Saudi Aramco. The company reported $18.67 billion in revenue for 2025, driven primarily by Starlink satellite internet growth and NASA contracts, though it continues to post significant losses tied to ambitious R&D in Starship and AI initiatives.
Important pieces moving forward include:
- Starlink Expansion: The satellite broadband service is scaling rapidly, targeting global connectivity, especially in underserved rural and remote areas. This segment offers massive recurring revenue potential as numbers climb.
- Starship and Reusability Leadership: SpaceX’s fully reusable Starship aims to slash launch costs dramatically, enabling frequent missions, Mars ambitions, and lucrative government/defense contracts. Success here could unlock exponential growth.
- AI and Diversification: Recent moves, including ties to xAI, position SpaceX in high-growth AI infrastructure, broadening beyond traditional aerospace.
- Validation Scrutiny: While the $1.75 trillion target excites investors, analysts like Morningstar value the company closer to $780 billion, citing high multiples (around 90x trailing revenue) and execution risks. A 180-day lockup period will prevent early investors like OTPP from selling immediately post-IPO.
The irony has not been lost on observers. Ontario’s government previously canceled a Starlink rural internet contract amid political tensions involving Musk, yet the pension fund’s savvy investment, made when SpaceX was valued around $33-36 billion, and Starlink was nascent, delivers outsized gains independent of politics.
For OTPP, this windfall strengthens its already solid 111 percent funding ratio and underscores the value of patient, innovation-focused capital allocation.
For SpaceX, the IPO marks a new chapter: greater transparency, access to public markets for talent retention and growth capital, and heightened pressure to deliver on its multi-planetary vision.
All eyes are fixed on whether SpaceX can justify its lofty valuation through sustained execution. For Ontario teachers, the returns are already stellar, but SpaceX, like other Musk companies in the past, has plenty of things to prove. Perhaps the most ideal person for the job is at the helm, hoping to bring the company to a massive valuation.
Tesla tipped its hand at where Robotaxi is heading next
Tesla Model 3’s cheapest trim just got a major accolade
